Back to search
Invasive Cryptococcosis
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Invasive Cryptococcosis trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Invasive Cryptococcosis trials you may qualify forThe purpose of this study is to determine if initial therapy with ABLC at 10/mg/kg/d for 7 days are at least effective as ABLC at 5.0 mg/kg/d X 14 days as induc…
This study is designed to evaluate the safety, tolerance and efficacy of Posaconazole (SCH 56592) under an open label, treatment protocol for subjects with inva…
This study is designed to evaluate the safety, tolerance and efficacy of Posaconazole (SCH 56592) under an open label, treatment protocol for subjects with inva…
This phase II study will be conducted to: 1. evaluate the pharmacokinetics, safety, tolerance, and efficacy of different dosing schedules of Posaconazole in im…
The purpose of this study is to evaluate the efficacy and safety of Vfend for the treatment of fungal infections